Quarterly report pursuant to Section 13 or 15(d)

Aytu Divestiture - Narrative (Details)

v3.21.1
Aytu Divestiture - Narrative (Details) - USD ($)
shares in Millions, $ in Millions
1 Months Ended 10 Months Ended 12 Months Ended 15 Months Ended
May 06, 2021
Nov. 01, 2019
Jun. 30, 2020
Oct. 31, 2019
Dec. 31, 2019
Jan. 31, 2021
Mar. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Remaining contingent consideration     $ 7.3        
Deerfield Obligation              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Contingent consideration paid       $ 3.2      
Periodic payment           $ 0.1  
Deerfield Obligation | AYTU              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Debt repayment     $ 15.0        
Remaining contingent consideration   $ 9.3          
AYTU | Maximum              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Duration of monthly commercial operation payments         18 months    
AYTU | Maximum | Subsequent Event              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Additional duration of monthly commercial operation payments 2 months            
AYTU | Convertible Preferred Stock              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Investment (in shares)         9.8    
Pediatric Portfolio | Deerfield Obligation | AYTU              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Future aggregate deferred payments   12.5          
Discontinued Operations, Disposed of by Sale | Pediatric Portfolio              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Proceeds from sale of assets         $ 4.5    
Sales returns disposed of   0.8          
Sales return reserve             $ 0.2
Discontinued Operations, Disposed of by Sale | Pediatric Portfolio | Maximum              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Sales returns disposed of   2.8          
Discontinued Operations, Disposed of by Sale | Pediatric Portfolio | Minimum              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Sales returns disposed of   $ 2.0